Brown University has reportedly become the fifth university to be targeted by the Trump administration for funding cuts, ...
Shortly after President Donald Trump took office this January, the White House rolled out an initiative designed to slash ...
Relay Therapeutics has laid off about 70 employees, the biotech's third round of cuts in less than a year. | Relay ...
Sangamo Therapeutics has stacked up $18 million cash from Eli Lilly in a licensing deal that will let the pharma use the ...
In this week’s episode of "The Top Line," Fierce Biotech’s Gabrielle Masson and Darren Incorvaia sit down to discuss a recent ...
As the Department of Health and Human Services grapples with the fallout of mass layoffs directed by Secretary Robert F.
After a drawn-out acquisition that closed in 2023, U.K. biotech F-star Therapeutics is charting its own path as a private, ...
Neurona Therapeutics has circled up $102 million to push its off-the-shelf cell therapy for epilepsy through phase 3 testing.
The home CPAP device maker Resmed is launching a small, disposable wearable to help diagnose cases of obstructive sleep apnea ...
Apollomics has tagged out of its partnership with TYG Oncology, terminating an immuno-oncology pact as part of a push to cut ...
The cuts impact more than $2.4 billion in grant money, including $1.3 billion in grant funds already spent on projects ...
The FDA has set back Aldeyra Therapeutics’ ambitions to win approval for its dry eye disease, rejecting its second ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results